Proliferation-stimulating effects of icaritin and desmethylicaritin in MCF-7 cells

被引:125
作者
Wang, ZQ [1 ]
Lou, YJ [1 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, Dept Pharmacol & Toxicol, Hangzhou 310031, Peoples R China
基金
中国国家自然科学基金;
关键词
icariin; icaritin; desmethylicaritin; phytoestrogen; estrogenic activity; cell cycle analysis; S phase; reverse transcriptase-polymerase chain reaction (RT-PCR);
D O I
10.1016/j.ejphar.2004.10.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Icariin, icaritin and desmethylicaritin are constituents of Epimedium with a similar structure to genistein and daidzein. Using the modified MCF-7 cell proliferation assay (E-SCREEN assessment system), these compounds were tested for their estrogen-like activities. Icaritin and desmethylicaritin, but not icariin, strongly stimulated the proliferation of MCF-7/BUS cells. Cell cycle analysis revealed that the proliferation stimulatory effect was associated with a marked increase in the number of MCF-7/BUS cells in S phase and a significant increase in the G2/ M population, with effects similar to those of estradiol. These actions were dose dependent (range from 1 nM to 10 muM) and could be significantly inhibited by the specific estrogen receptor antagonist ICI 182,780 [7 alpha-[9(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl)-estra-1,3,5(10)-triene-3,17beta-diol)]. The estrogen receptor-regulated progesterone receptor and PS2 mRNA levels were increased by treatment with icaritin or desmethylicaritin within 24 h and the effects were also reversed by ICI 182,780. It was concluded that icaritin and desmethylicaritin are novel phytoestrogens and that the estrogenic effects of icaritin and desmethylicaritin are mediated by the estrogen receptor. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 30 条
[1]   Phyto-oestrogens: Where are we now? [J].
Bingham, SA ;
Atkinson, C ;
Liggins, J ;
Bluck, L ;
Coward, A .
BRITISH JOURNAL OF NUTRITION, 1998, 79 (05) :393-406
[2]   Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay [J].
Breinholt, V ;
Larsen, JC .
CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (06) :622-629
[3]  
Calliste CA, 2001, ANTICANCER RES, V21, P3949
[4]   Non-transcriptional action of oestradiol and progestin triggers DNA synthesis [J].
Castoria, G ;
Barone, MV ;
Di Domenico, M ;
Bilancio, A ;
Ametrano, D ;
Migliaccio, A ;
Auricchio, F .
EMBO JOURNAL, 1999, 18 (09) :2500-2510
[5]   Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms [J].
Collins-Burow, BM ;
Burow, ME ;
Duong, BN ;
McLachlan, JA .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2000, 38 (02) :229-244
[6]  
Cos P, 2003, PLANTA MED, V69, P589, DOI 10.1055/s-2003-41122
[7]   ANTIESTROGEN ICI-164,384 REDUCES CELLULAR ESTROGEN-RECEPTOR CONTENT BY INCREASING ITS TURNOVER [J].
DAUVOIS, S ;
DANIELIAN, PS ;
WHITE, R ;
PARKER, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :4037-4041
[8]   Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype [J].
Frasor, J ;
Danes, JM ;
Komm, B ;
Chang, KCN ;
Lyttle, CR ;
Katzenellenbogen, BS .
ENDOCRINOLOGY, 2003, 144 (10) :4562-4574
[9]   THE MECHANISM OF ICI-164,384 ANTIESTROGENICITY INVOLVES RAPID LOSS OF ESTROGEN-RECEPTOR IN UTERINE TISSUE [J].
GIBSON, MK ;
NEMMERS, LA ;
BECKMAN, WC ;
DAVIS, VL ;
CURTIS, SW ;
KORACH, KS .
ENDOCRINOLOGY, 1991, 129 (04) :2000-2010
[10]   The multifaceted mechanisms of estradiol and estrogen receptor signaling [J].
Hall, JM ;
Couse, JF ;
Korach, KS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (40) :36869-36872